Pulmonary tuberculosis
Tuberculosis, commonly known as "pulmonary tuberculosis", is a highly contagious chronic wasting disease caused by the invasion of Mycobacterium tuberculosis into the human body. It is not affected by age, gender, race, occupation, or region. Many organs and systems of the human body can be infected with tuberculosis, among which pulmonary tuberculosis is the most common. More than 90% of pulmonary tuberculosis is transmitted through the respiratory tract. Tuberculosis patients cough, sneeze, and shout loudly, causing droplets containing tuberculosis bacteria to be sprayed out of the body, and healthy people are infected after inhaling them. Its typical manifestations are: coughing, sputum, hemoptysis, chest pain, and difficulty breathing. It is a chronic infectious disease that has a long history of endangering human health. It once spread all over the world and caused millions of deaths. my country is now one of the 22 countries with a high burden of tuberculosis in the world, and the number of tuberculosis patients ranks second in the world, second only to India. At present, there are an estimated 2 million infectious pulmonary tuberculosis patients in my country.
-
Site of disease:
lung -
Infectious :
Contagious -
Frequent population:
All people, mainly middle-aged and elderly people -
Related symptoms:
Low fever loss of appetite fatigue cough facial flushing -
Concurrent disease:
Related Drugs
Isoniazid Tablets
Indication: 1. Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. 2. Isoniazid alone is suitable for the prevention of various types of tuberculosis: 1. Family members or close contacts of patients recently diagnosed with tuberculosis; 2. Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; 3. Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose tuberculin purified protein derivative test is positive; 4. Patients under 35 years old with a positive tuberculin purified protein derivative test; 5. People who are known or suspected to be infected with HIV, whose tuberculin purified protein derivative test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Manufacturer:
Fuzhou FU Yao Pharmaceutical Co., Ltd.
Isoniazid Tablets
Indication: 1. Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. 2. Isoniazid alone is suitable for the prevention of various types of tuberculosis: 1. Family members or close contacts of patients recently diagnosed with tuberculosis; 2. Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; 3. Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose tuberculin purified protein derivative test is positive; 4. Patients under 35 years old with a positive tuberculin purified protein derivative test; 5. People who are known or suspected to be infected with HIV, whose tuberculin purified protein derivative test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Isoniazid Tablets
Indication: 1. Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. 2. Isoniazid alone is suitable for the prevention of various types of tuberculosis: 1. Family members or close contacts of patients recently diagnosed with tuberculosis; 2. Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; 3. Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose tuberculin purified protein derivative test is positive; 4. Patients under 35 years old with a positive tuberculin purified protein derivative test; 5. People who are known or suspected to be infected with HIV, whose tuberculin purified protein derivative test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Isoniazid Tablets
Indication: 1. Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. 2. Isoniazid alone is suitable for the prevention of various types of tuberculosis: 1. Family members or close contacts of patients recently diagnosed with tuberculosis; 2. Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; 3. Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose tuberculin purified protein derivative test is positive; 4. Patients under 35 years old with a positive tuberculin purified protein derivative test; 5. People who are known or suspected to be infected with HIV, whose tuberculin purified protein derivative test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Isoniazid Tablets
Indication: 1. Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. 2. Isoniazid alone is suitable for the prevention of various types of tuberculosis: 1. Family members or close contacts of patients recently diagnosed with tuberculosis; 2. Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; 3. Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose tuberculin purified protein derivative test is positive; 4. Patients under 35 years old with a positive tuberculin purified protein derivative test; 5. People who are known or suspected to be infected with HIV, whose tuberculin purified protein derivative test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Manufacturer:
Ningxia QIYUAN Chinese MEDICINE Co., Ltd.
Isoniazid Tablets
Indication: 1. Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. 2. Isoniazid alone is suitable for the prevention of various types of tuberculosis: 1. Family members or close contacts of patients recently diagnosed with tuberculosis; 2. Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; 3. Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose tuberculin purified protein derivative test is positive; 4. Patients under 35 years old with a positive tuberculin purified protein derivative test; 5. People who are known or suspected to be infected with HIV, whose tuberculin purified protein derivative test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Manufacturer:
Sinopharm Medicine Holding Xingsha Pharmaceutical (Xiamen) Co., Ltd.
Isoniazid Tablets
Indication: 1. Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. 2. Isoniazid alone is suitable for the prevention of various types of tuberculosis: 1. Family members or close contacts of patients recently diagnosed with tuberculosis; 2. Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; 3. Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose tuberculin purified protein derivative test is positive; 4. Patients under 35 years old with a positive tuberculin purified protein derivative test; 5. People who are known or suspected to be infected with HIV, whose tuberculin purified protein derivative test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Isoniazid Tablets
Indication: 1. Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. 2. Isoniazid alone is suitable for the prevention of various types of tuberculosis: 1. Family members or close contacts of patients recently diagnosed with tuberculosis; 2. Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; 3. Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose tuberculin purified protein derivative test is positive; 4. Patients under 35 years old with a positive tuberculin purified protein derivative test; 5. People who are known or suspected to be infected with HIV, whose tuberculin purified protein derivative test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Isoniazid Tablets
Indication: 1. Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. 2. Isoniazid alone is suitable for the prevention of various types of tuberculosis: 1. Family members or close contacts of patients recently diagnosed with tuberculosis; 2. Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; 3. Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose tuberculin purified protein derivative test is positive; 4. Patients under 35 years old with a positive tuberculin purified protein derivative test; 5. People who are known or suspected to be infected with HIV, whose tuberculin purified protein derivative test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Isoniazid Tablets
Indication: 1. Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. 2. Isoniazid alone is suitable for the prevention of various types of tuberculosis: 1. Family members or close contacts of patients recently diagnosed with tuberculosis; 2. Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; 3. Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose tuberculin purified protein derivative test is positive; 4. Patients under 35 years old with a positive tuberculin purified protein derivative test; 5. People who are known or suspected to be infected with HIV, whose tuberculin purified protein derivative test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Manufacturer:
Shanghai Worldbest Anhui JINHUI Pharmaceutical Co., Ltd.
Related Ingredients